HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.

AbstractPURPOSE:
Our aims in this pilot study were to determine whether fine needle aspirates (FNAs) provide a sufficient quantity of mRNA for cDNA microarray analysis, produce a set of quality control criteria to accept individual arrays, and determine whether gene expression profiles obtained from FNAs were representative of the source tumor.
EXPERIMENTAL DESIGN:
Twenty-seven women with breast cancer for treatment with primary surgery had a FNA before and at the time of surgery, and a portion of excised tumor was taken for array analysis. Control experiments were performed using two Ewing's sarcoma xenograft models. mRNA was extracted from the samples and hybridized with the reference (MCF7 cell line) on cDNA microarrays. Statistical methods were applied to identify acceptability criteria for the arrays.
RESULTS:
Statistical analyses demonstrated that an adequate array could be identified by calculating the SD of the log of fluorescence intensities from the arrays. Using this criterion, only 4 of the 27 patients (15%) had FNA samples suitable for array analysis. Gene expression profiles from the FNAs closely resembled that of the corresponding source tumors and were clearly distinguished from FNAs derived from the xenografts.
CONCLUSIONS:
SD is a useful quality index for the clinical application of cDNA microarrays. This "proof of principle" study demonstrates that FNAs from primary breast cancers can be used for microarray analysis, although without amplification, it is feasible in only a small proportion of patients. For this to be clinically useful, validated amplification techniques for FNA samples are probably required.
AuthorsLaura Assersohn, Lisa Gangi, Yingdong Zhao, Mitch Dowsett, Richard Simon, Trevor J Powles, Edison T Liu
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 8 Issue 3 Pg. 794-801 (Mar 2002) ISSN: 1078-0432 [Print] United States
PMID11895911 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • RNA, Messenger
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Biopsy, Needle
  • Breast Neoplasms (genetics)
  • Carcinoma, Intraductal, Noninfiltrating (genetics)
  • DNA, Neoplasm (analysis)
  • Feasibility Studies
  • Female
  • Gene Expression Profiling
  • Humans
  • Mice
  • Mice, Nude
  • Mice, SCID
  • Middle Aged
  • Neoplasm Invasiveness
  • Oligonucleotide Array Sequence Analysis (methods)
  • Pilot Projects
  • RNA, Messenger (analysis)
  • Reproducibility of Results
  • Tumor Cells, Cultured (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: